Diabetes mellitus: diagnosis and screening

Area of Science:

• Endocrinology
• Diabetes Mellitus Research
• Diagnostic Testing

Background:

• Diabetes mellitus encompasses various types, including type 1, type 2, latent autoimmune diabetes, and maturity-onset diabetes of youth.
• Accurate diagnosis and classification are crucial for effective patient management.
• Screening for diabetes is recommended in patients with hypertension or hyperlipidemia, despite guideline variations.

Purpose of the Study:

• To review the classification and diagnostic approaches for diabetes mellitus.
• To highlight the utility of risk calculators and specific laboratory tests in diabetes diagnosis and management.
• To discuss the role and limitations of antibody testing in determining diabetes type and insulin dependence.

Main Methods:

• Review of current literature on diabetes classification and diagnostic criteria.
• Analysis of the role of A1C, blood glucose levels, and oral glucose tolerance testing in diagnosis.
• Evaluation of diabetes risk calculators and their predictive value.
• Examination of tests for beta cell function (C-peptide) and autoimmune markers (autoantibodies).

Main Results:

• Diabetes is classified based on etiology, with diagnosis relying on glycemic measurements.
• Diabetes risk calculators demonstrate high negative predictive value, identifying low-risk individuals.
• Tests assessing beta cell function and autoantibodies can help differentiate diabetes types and guide insulin therapy.
• Antibody testing, while informative, is constrained by availability, cost, and predictive accuracy.

Conclusions:

• Effective diabetes management requires accurate classification and diagnosis using established and emerging tools.
• Risk stratification tools and specific biomarkers play a role in identifying individuals who may benefit from further testing.
• Further research may address the limitations of current antibody testing for autoimmune diabetes markers.